Results
|
|
641.
|
|
|
|
642.
|
|
|
|
643.
|
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker. [electronic resource] by
- Ramlau, Rodryg
- Thomas, Michael
- Novello, Silvia
- Plummer, Ruth
- Reck, Martin
- Kaneko, Tomomi
- Lau, Mike R
- Margetts, Jane
- Lunec, John
- Nutt, Joyce
- Scagliotti, Giorgio V
Producer: 20160406
In:
Clinical lung cancer vol. 16
Availability: No items available.
|
|
|
644.
|
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases. [electronic resource] by
- Lin, Nancy U
- Freedman, Rachel A
- Ramakrishna, Naren
- Younger, Jerry
- Storniolo, Anna Maria
- Bellon, Jennifer R
- Come, Steven E
- Gelman, Rebecca S
- Harris, Gordon J
- Henderson, Mark A
- Macdonald, Shannon M
- Mahadevan, Anand
- Eisenberg, Emily
- Ligibel, Jennifer A
- Mayer, Erica L
- Moy, Beverly
- Eichler, April F
- Winer, Eric P
Producer: 20140814
In:
Breast cancer research and treatment vol. 142
Availability: No items available.
|
|
|
645.
|
|
|
|
646.
|
|
|
|
647.
|
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. [electronic resource] by
- Spraggs, C F
- Parham, L R
- Briley, L P
- Warren, L
- Williams, L S
- Fraser, D J
- Jiang, Z
- Aziz, Z
- Ahmed, S
- Demetriou, G
- Mehta, A
- Jackson, N
- Byrne, J
- Andersson, M
- Toi, M
- Harris, L
- Gralow, J
- Zujewski, J A
- Crescenzo, R
- Armour, A
- Perez, E
- Piccart, M
Producer: 20190111
In:
The pharmacogenomics journal vol. 18
Availability: No items available.
|
|
|
648.
|
|
|
|
649.
|
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis. [electronic resource] by
- Fleeman, N
- Bagust, A
- Boland, A
- Dickson, R
- Dundar, Y
- Moonan, M
- Oyee, J
- Blundell, M
- Davis, H
- Armstrong, A
- Thorp, N
Producer: 20120403
In:
Health technology assessment (Winchester, England) vol. 15
Availability: No items available.
|
|
|
650.
|
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. [electronic resource] by
- Rugo, Hope S
- Chien, A Jo
- Franco, Sandra X
- Stopeck, Alison T
- Glencer, Alexa
- Lahiri, Soumi
- Arbushites, Michael C
- Scott, Janet
- Park, John W
- Hudis, Clifford
- Nulsen, Ben
- Dickler, Maura N
Producer: 20121119
In:
Breast cancer research and treatment vol. 134
Availability: No items available.
|
|
|
651.
|
|
|
|
652.
|
|
|
|
653.
|
|
|
|
654.
|
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer. [electronic resource] by
- Guarneri, Valentina
- Dieci, Maria Vittoria
- Frassoldati, Antonio
- Maiorana, Antonino
- Ficarra, Guido
- Bettelli, Stefania
- Tagliafico, Enrico
- Bicciato, Silvio
- Generali, Daniele Giulio
- Cagossi, Katia
- Bisagni, Giancarlo
- Sarti, Samanta
- Musolino, Antonino
- Ellis, Catherine
- Crescenzo, Rocco
- Conte, PierFranco
Producer: 20160621
In:
The oncologist vol. 20
Availability: No items available.
|
|
|
655.
|
|
|
|
656.
|
|
|
|
657.
|
|
|
|
658.
|
[Mechanism underlying inhibition of proliferation and promotion of apoptosis by lapatinib in HL60 cells]. [electronic resource] by
- Liu, Lu
- Liu, Beizhong
- Zhao, Yi
- Chen, Min
- Yao, Shifei
- Li, Lianwen
- Xiao, Chunlan
- Shan, Zhiling
- Xu, Ting
- Gan, Liugen
- Zhong, Liang
Producer: 20180515
In:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology vol. 33
Availability: No items available.
|
|
|
659.
|
|
|
|
660.
|
|